GE HealthCare to acquire the remaining 50% stake in Nihon Medi-Physics from Sumitomo Chemical.

GE HealthCare, a global medical technology, pharmaceutical diagnostics, and digital solutions innovator, agreed to acquire the remaining 50% stake in Nihon Medi-Physics, a pharmaceutical manufacturing firm, from Sumitomo Chemical, a major Japanese chemical company. Financial terms were not disclosed. As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease.